CIK 0001857044 · Non-accelerated filer<br>Smaller reporting company
Indaptus Therapeutics, Inc.
Sign in to watch- Ticker
- INDP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863158720
- Phone
- (646) 427-2727
- Business address
- 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK, NY, 10019
- Former names
- Intec Parent Inc.
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Chief Executive Officer acquired 6,068 shares (grant or award)
- 8-K Event Unregistered share sale · Shareholder vote results
- 8-K Event Other events
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Other events
- DEF 14A Proxy Proxy Statement
- D Other Notice of Sales of Unregistered Securities
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 18 · 343 filings